Dernières nouvelles pour Trevi Therapeutics (NASDAQ:TRVI) Stock

Trevi Therapeutics

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

Trevi Therapeutics Inc

News about Google is permeating the airways with headlines about the continued rise in quantum computing abilities as well as Congress threatening to make Google's parent company, Alphabet, sell off the web browser Chrome.
This cross current of aggressive news headlines predicts a fair move to either the upside or downside. Let's consider giving this trade 20 days or so to work itself out. Hence, our expiration will be the January 2025 monthly options.
Here's how to structure the trade.
In this situation, I'm looking at a long double butterfly, with a twist.
A double butterfly is ideal for larger anticipated moves into a catalyst like earnings or a spike in news and follow through. This setup is a combination of a long call butterfly and a long put butterfly.
A long call butterfly is the combination of a long call spread, and a short call spread that share the same short strike. A long put butterfly is the combination of a long put spread and a short put spread that share the same short strike. They are positioned as two separate trades.
Here's the ‘twist' part – because my expectation is that the trade action will be volatile, I have adjusted the butterflies to sell more of the options further away – but have made the distance off the strikes closer so that we do not incur margin requirements.
The long call butterfly (positioned for measured upside)
<ul>
<li>Buy to open 1 GOOG 17 Jan 200 calls</li>
<li>Sell to open 3 GOOG 17 Jan 210 calls</li>
<li>Buy to open 2 GOOG 17 Jan 215 calls</li>
</ul>
The long put butterfly (positioned for downside)
<ul>
<li>Buy to open 1 GOOG 17 Jan 175 puts</li>
<li>Sell to open 3 GOOG 17 Jan 165 puts</li>
<li>Buy to open 2 GOOG 17 Jan 160 puts</li>
</ul>
The long call butterfly holds a current debit of 0.27 at this writing and the long put butterfly holds a current debit of 0.30. Together, the total risk is the debit you have paid for both butterflies, but if you have a definitive bias, you can engage in only one of them. &nbsp;
The total potential profit is $10 times 100 (the distance between strikes times 100 as one option controls 100 shares) making the cost of the debit (0.27 + 0.30=.57) times 100. In other words, $1000 -$57 = $943.
It is extremely rare to collect all this premium. Instead, I like to consider 200%-300% profit of the investment. A key part of trading success and consistency comes from managing expectation.
The reason I chose these strikes is because GOOG's support and resistance levels. The relative resistance zone is right around $200, and this latest spike came with lower volume so even if it could run, it may not run far before reversing. The relative support is near $175.
The strategy result provides only two choices to exit the trade:
<ol>
<li>To sell the butterfly that is performing at your target parameters &#8211; particularly once the middle strike is tested.</li>
<li>To sell the both butterflies with ten days to expiration if there is no movement in price, if the chart does nothing, or once your threshold for loss is hit. Mine is typically 65-70% with these positions.</li>
</ol>
December 15th: Get a complete blueprint for transforming market volatility into high-probability trades. <a href="https://bzresearch.myclickfunnels.com/earnings-gaps-masterclass-registration/?utm_source=WebRD-1212">REGISTER FREE NOW</a>
Image via Google

Opinion

Trading Ideas

How to Trade Google's Batch of Great and Horrible News

WIIM

INTC

Intel shares are trading higher. A report from Reuters suggested the company may be considering spinning off its foundry operation,

Nikola Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKLA#NASDAQ">NKLA</a>) shares are trading lower Thursday following a report indicating the company confirmed another <a href="https://www.benzinga.com/news/24/12/42417814/whats-going-on-with-nikola-stock-5">round of layoffs</a>.
What Happened: Nikola has confirmed a fresh round of layoffs just months after the company slashed approximately 15% of its workforce as it attempts to avoid bankruptcy, according to <a href="https://electrek.co/2024/12/12/nikola-nkla-confirms-more-layoffs-as-it-desperately-tries-to-avoid-bankruptcy/">Electrek</a>.
The report indicates that it&#8217;s not clear how many employees will be affected by the new round of layoffs this month. However, a drone flyover of Nikola&#8217;s Arizona factory reportedly showed &#8220;less activity than usual&#8221; and many trucks parked &#8220;without battery packs.&#8221;
Elektrek also reported that Nikola is running out of cash and launched a $100 million offering, but noted that the company has not announced the closing of that offering. 
Check This Out: <a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42469214/stocks-slip-on-hot-inflation-data-adobe-tumbles-natural-gas-hits-1-year-high-whats-driving-markets-thursday">Stocks Slip On Hot Inflation Data, Adobe Tumbles, Natural Gas Hits 1-Year High: What&#8217;s Driving Markets Thursday?</a>
Nikola said in a regulatory filing on Monday that it needs to raise additional capital to avoid negatively impacting operations.
&#8220;We currently estimate that our existing financial resources are only adequate to fund our forecasted operating costs and meet our obligations into, but not through, the&nbsp;first quarter&nbsp;of 2025,&#8221; the company said in the filing. 
The report indicates that Nikola is losing approximately $200 million per quarter. Nikola had approximately $198 million in cash as of Sept. 30. 
NKLA Price Action: <a href="http://benzinga.com/quote/nkla">Nikola shares</a> were down 0.31% at $1.57 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: courtesy of Nikola.

News

Movers

NKLA

What's Going On With Nikola Stock Thursday?

McKesson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCK#NYSE">MCK</a>) has outperformed the market over the past 15 years by 3.86% on an annualized basis producing an average annual return of 15.88%. Currently, McKesson has a market capitalization of $75.06 billion. 
Buying $1000 In MCK: If an investor had bought $1000 of MCK stock 15 years ago, it would be worth $9,068.79 today based on a price of $578.68 for MCK at the time of writing.
<h3>McKesson's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734035748_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In McKesson 15 Years Ago Would Be Worth Today

RGTI

Rigetti Computing shares are trading lower, pulling back following recent volatility.

When it comes to retirement savings, <a href="https://www.benzinga.com/personal-finance/24/10/41193824/are-you-rich-enough-to-be-in-the-top-1-heres-both-the-income-and-net-worth-you-need-to-rank-amon">hitting the $5 million mark</a> is like joining an ultraexclusive club – so exclusive that less than 0.1% of retirees manage to achieve it.&nbsp;
According to data from the Employee Benefit Research Institute, based on the Federal Reserve's Survey of Consumer Finances, this tiny fraction of Americans have amassed retirement savings that most people can only dream of. Even reaching the $1 million milestone is uncommon, with just 3.2% of retirees achieving that goal.
Don't Miss:
<ul>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
<li><a href="https://www.benzinga.com/money/cd-valet-growth">CD Popularity Soars: Over 50 Million Americans Embrace Safe Savings with 5–10% Annual Growth</a></li>
</ul>
So, who are these rare individuals sitting on $5 million nest eggs? Surprisingly, many didn't start with this goal in mind. What sets them apart are consistent saving habits, modest lifestyles and a willingness to keep working – even if only part-time – well into their retirement years. A mix of discipline and smart choices adds up over time.
For context, let's talk averages. Vanguard's 2022 data shows that the typical retirement account balance for individuals aged 65 or older was just $232,710. That means someone with $5 million has over 21 times the savings of the average retiree. Meanwhile, according to the Federal Reserve, the median retirement savings for all U.S. households sits at just $87,000. Half of American families don't have retirement accounts and another 22% have less than $50,000 saved.
See Also: The number of ‘401(k)' Millionaires is up 43% from last year —<a href="https://www.benzinga.com/money/401k-millionaires"> Here are three ways to join the club.</a>
This kind of gap makes you stop and think: What are they doing differently?
Many of those who <a href="https://www.benzinga.com/24/11/42173927/how-rich-are-you-find-out-whether-you-rank-as-upper-middle-or-lower-class-based-on-income-and-other-factors">manage to save millions </a>for retirement start saving and investing early, letting compound interest work its magic over decades. Consistency is key too: while the <a href="https://www.benzinga.com/personal-finance/24/09/41075540/is-your-401-k-balance-above-average-find-out-if-youre-beating-most-savers">average 401(k) employee</a> contributes 7.4% of their salary, often matched by 4.6% from their employer, high-net-worth individuals typically save at even higher rates.
But it's not just about saving. These retirees often diversify their income streams with investments, rental properties or part-time work. They're also savvy about taxes, using strategies to keep more of their money working for them.&nbsp;
Trending: Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Last Chance to get 4,000 of its pre-IPO shares for just $0.26/share!</a>
The reality is that a $5 million retirement isn't a realistic goal for most people – and that's okay. A comfortable retirement is still within reach if you plan wisely and stay disciplined. This is where a <a href="https://www.benzinga.com/money/can-you-guess-how-many-americans-successfully-retire-with-1-million-saved">financial advisor can make a huge difference</a>. They can help you craft a personalized plan that aligns with your income, savings and lifestyle goals, maximizing your chances of financial security in retirement.
Whether your goal is $5 million or much smaller, the path to a secure retirement starts with taking control of your financial future. And while you might not join the ultra-wealthy 0.1%, you can still achieve a lifestyle that feels rich in its way.
Read Next:
<ul>
<li>Many are using this retirement income calculator to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a></li>
<li>Studies show 50% of consumers think Financial Advisors cost much more than they do —<a href="https://www.benzinga.com/money/money-pickle"> to debunk this, this company provides matching for free and a complimentary first call with the matched advisor.</a></li>
</ul>

Personal Finance

Can You Guess What Percent Of People Retire With A $5 Million Nest Egg? Hint: It's Way Less Than 1%

Cryptocurrency markets are trading lower on Thursday as President-elect Donald Trump rang the bell at the <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42466189/trump-talks-stocks-bitcoin-ai-economy-with-jim-cramer-youre-going-to-see-some-very-good-days-ahead">New York Stock Exchange</a>.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$99,666.97</td>
<td>-1.7%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$3,882.77</td>
<td>+1.8%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$228.16</td>
<td>-0.9%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$2.36</td>
<td>-3.2%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.404</td>
<td>-3.2%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00002804</td>
<td>-4%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul>
<li>IntoTheBlock data shows large transaction volume increasing by 5.3% and daily active addresses falling by 11.9%. Transactions greater than $100,000 remained relatively flat while exchanges netflows are up by 308.9%.</li>
<li>Coinglass data reports 100,126 traders were liquidated in the past 24 hours for $290.48 million.</li>
</ul>
Notable Developments:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42463001/blackrock-advocates-for-2-bitcoin-allocation-in-multi-asset-portfolios">BlackRock Advocates For 2% Bitcoin Allocation In Multi-Asset Portfolios</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42457605/exclusive-experts-share-their-top-crypto-predictions-for-2025">EXCLUSIVE: Experts Share Their Top Crypto Predictions For 2025</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42470280/waterfall-network-raises-116-million-to-enhance-blockchain-scalability-and-decentralization">Waterfall Network Raises $11.6 Million To Enhance Blockchain Scalability And Decentralization</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42453467/japanese-crypto-behemoth-coincheck-enters-wall-street-with-nasdaq-listing">Japan&#8217;s Coincheck Crypto Exchange Enters Wall Street With Nasdaq Listing</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42469967/elon-musk-vivek-ramaswamy-slam-sec-just-another-weaponized-institution">Elon Musk, Vivek Ramaswamy Slam SEC: &#8216;Just Another Weaponized Institution&#8217;</a></li>
</ul>
Top Gainers:
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Aave (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/aave/usd">AAVE</a>)</td>
<td>&nbsp;$359.71</td>
<td>+23.9%</td>
</tr>
<tr>
<td>Lido DAO (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">LDO</a>)</td>
<td>&nbsp;$2.27</td>
<td>+20%</td>
</tr>
<tr>
<td>Chainlink (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/link/usd">LINK</a>)</td>
<td>&nbsp;$26.98</td>
<td>+12.9%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: With Bitcoin prices breaking the $100,000 mark, crypto trader Jelle sees a potential drop back to $97,000 from here. He added that this could be for scaring traders and then a "real breakout."
Jelle is expecting a "true breakout before Christmas &#8212; 2025 is going to be a crazy ride."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Would be classic <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> to drop back to $97,000 from here &#8211; make everyone scared as shit &amp; then pump back for the real breakout &#39;muh dead cat bounce! &#x1f972;&#39; <a href="https://t.co/V22GRQqWbX">pic.twitter.com/V22GRQqWbX</a>
&mdash; Jelle (@CryptoJelleNL) <a href="https://twitter.com/CryptoJelleNL/status/1867286481771147686?ref_src=twsrc%5Etfw">December 12, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto trader Javon Marks <a href="https://x.com/JavonTM1/status/1867231557347389451">sees</a> Bitcoin trading well above the $67,559 level, indicating a bullish setup. 
The next target is $116,652, representing a potential 15% move higher. A breakout above this level could pave the way for further gains, with more than $165,000 as the subsequent target.
Crypto trader Nic <a href="https://x.com/nicrypto/status/1867253140673696154">predicts</a> an "explosive BTC price action" as the 20-day Bollinger band bandwidth is at its lowest level in months. He advises, "Keep an eye out for an upside breakout above the upper band."
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/events/24/12/42467627/how-bitcoin-etfs-are-changing-the-way-institutions-manage-risk-according-to-experts">How Bitcoin ETFs Are Changing The Way Institutions Manage Risk According To Experts</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$AAVE

$BTC

$DOGE

$ETH

$LDO

$LINK

$SHIB

$SOL

$XRP

Bitcoin, XRP, Dogecoin Move Down, Ethereum The Best Of The Bunch: 'Expecting True Breakout Before Christmas,' Announces Trader

AMPG

AmpliTech shares are trading higher following earlier reports that the company priced a $2.2 million registered direct offering of 1.35 million shares at $1.60 per share.

ADNT

PRTS

Shares of auto supplier stocks are trading lower. Weakness may be in reaction to worse-than-expected November PPI data, which could cloud rate cut outlook.

Mueller Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLI#NYSE">MLI</a>) has outperformed the market over the past 20 years by 4.06% on an annualized basis producing an average annual return of 12.46%. Currently, Mueller Industries has a market capitalization of $9.56 billion. 
Buying $100 In MLI: If an investor had bought $100 of MLI stock 20 years ago, it would be worth $1,032.18 today based on a price of $84.09 for MLI at the time of writing.
<h3>Mueller Industries's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734034594_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Mueller Industries Stock In The Last 20 Years

Shares of homebuilders are trading lower. Weakness may be in reaction to worse-than-expected November PPI data, which could cloud rate cut outlook.

In the current market session, PayPal Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>) stock price is at $90.43, after a 0.35% drop. However, over the past month, the company's stock went up by 4.63%, and in the past year, by 46.52%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2024/1734034517_0.png" alt="Past Year Chart" />

<h3>How Does PayPal Holdings P/E Compare to Other Companies?</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
PayPal Holdings has a lower P/E than the aggregate P/E of 48.61 of the Financial Services industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1734034517_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

PYPL

Price Over Earnings Overview: PayPal Holdings

Community Health Systems Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) shares are trading lower by 7% to $3.38 Thursday afternoon. The company announced a definitive agreement to sell its North Carolina Hospital to Duke Health for <a href="https://www.benzinga.com/pressreleases/24/12/b42448292/community-health-systems-announces-definitive-agreement-to-sell-north-carolina-hospital-to-duke-he">approximately $280 million</a>.
What Else: Community Health Systems announced that a subsidiary has entered a definitive agreement to sell the 123-bed Lake Norman Regional Medical Center in Mooresville, N.C., and related businesses to Duke Health for approximately $280 million, pending adjustments. 
The transaction, expected to close in first-quarter 2025, is subject to regulatory approvals and other conditions. The sale aligns with the company&#8217;s previously discussed plans for potential divestitures, as highlighted during its third-quarter 2024 earnings call.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42469214/stocks-slip-on-hot-inflation-data-adobe-tumbles-natural-gas-hits-1-year-high-whats-driving-markets-thursday">Stocks Slip On Hot Inflation Data, Adobe Tumbles, Natural Gas Hits 1-Year High: What&#8217;s Driving Markets Thursday?</a>
<h2 class="wp-block-heading">How To Buy CYH Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Community Health Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>)'s case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

Why Community Health Systems (CYH) Stock Is Falling

Investors with a lot of money to spend have taken a bullish stance on Spotify Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with SPOT, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 12 options trades for Spotify Technology.
This isn't normal.
The overall sentiment of these big-money traders is split between 75% bullish and 25%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $41,945, and 11, calls, for a total amount of $416,620.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $105.0 and $500.0 for Spotify Technology, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for Spotify Technology options trades today is 39.0 with a total volume of 65.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Spotify Technology's big money trades within a strike price range of $105.0 to $500.0 over the last 30 days.
<h3>Spotify Technology Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734034177_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SPOT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$77.4</td>
<td>$76.0</td>
<td>$76.0</td>
<td>$460.00</td>
<td>$60.8K</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>SPOT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$41.95</td>
<td>$41.9</td>
<td>$41.9</td>
<td>$460.00</td>
<td>$41.9K</td>
<td align="right">40</td>
<td align="right">13</td>
</tr>
<tr>
<td>SPOT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$385.55</td>
<td>$382.2</td>
<td>$385.55</td>
<td>$105.00</td>
<td>$38.5K</td>
<td align="right">0</td>
<td align="right">2</td>
</tr>
<tr>
<td>SPOT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$385.35</td>
<td>$382.0</td>
<td>$385.35</td>
<td>$105.00</td>
<td>$38.5K</td>
<td align="right">0</td>
<td align="right">2</td>
</tr>
<tr>
<td>SPOT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$381.2</td>
<td>$378.0</td>
<td>$381.2</td>
<td>$110.00</td>
<td>$38.1K</td>
<td align="right">0</td>
<td align="right">2</td>
</tr>
</tbody>
</table>

<h3>About Spotify Technology</h3>
Spotify is the leading global music streaming service provider, with over 600 million monthly active users and 250 million paying subscribers, with the latter comprising the firm's premium segment. most of the firm's revenue and nearly all its gross profit come from the subscribers, who pay a monthly fee to access a very comprehensive music library that consists of most of the most popular songs ever recorded, including all from the major record labels. The firm also sells separate audiobook subscriptions and integrates podcasts within its standard music app. Podcast content is not exclusive and is typically free to access on other platforms. Ad-supported users can access a similar music catalog but cannot customize a similar on-demand experience.
In light of the recent options history for Spotify Technology, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of Spotify Technology</h3>
<ul>
<li>With a trading volume of 1,016,422, the price of SPOT is up by 1.15%, reaching $482.38.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 54 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Spotify Technology</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $500.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Macquarie persists with their Outperform rating on Spotify Technology, maintaining a target price of $500. 
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on Spotify Technology with a target price of $475. 
&#x2A; An analyst from Phillip Securities downgraded its action to Accumulate with a price target of $485. 
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Buy rating on Spotify Technology with a target price of $515. 
&#x2A; An analyst from Canaccord Genuity persists with their Buy rating on Spotify Technology, maintaining a target price of $525. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Spotify Technology with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

SPOT

Looking At Spotify Technology's Recent Unusual Options Activity

Whales with a lot of money to spend have taken a noticeably bullish stance on Lam Research.
Looking at options history for Lam Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>) we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 37% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $1,398,938 and 3, calls, for a total amount of $284,388.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $67.0 and $90.0 for Lam Research, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Lam Research's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Lam Research's whale trades within a strike price range from $67.0 to $90.0 in the last 30 days. 
<h3>Lam Research Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734034172_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LRCX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$13.5</td>
<td>$13.3</td>
<td>$13.3</td>
<td>$80.00</td>
<td>$861.8K</td>
<td>2.8K</td>
<td align="right">698</td>
</tr>
<tr>
<td>LRCX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$4.35</td>
<td>$4.3</td>
<td>$4.35</td>
<td>$74.00</td>
<td>$217.9K</td>
<td>6.4K</td>
<td align="right">8</td>
</tr>
<tr>
<td>LRCX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$6.5</td>
<td>$6.4</td>
<td>$6.4</td>
<td>$85.00</td>
<td>$208.0K</td>
<td>367</td>
<td align="right">326</td>
</tr>
<tr>
<td>LRCX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$4.4</td>
<td>$4.3</td>
<td>$4.35</td>
<td>$67.00</td>
<td>$188.8K</td>
<td>1.2K</td>
<td align="right">438</td>
</tr>
<tr>
<td>LRCX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.9</td>
<td>$1.83</td>
<td>$1.84</td>
<td>$72.00</td>
<td>$92.0K</td>
<td>4.7K</td>
<td align="right">15</td>
</tr>
</tbody>
</table>

<h3>About Lam Research</h3>
Lam Research is one of the largest semiconductor wafer fabrication equipment manufacturers in the world. It specializes in deposition and etch, which entail the buildup of layers on a semiconductor and the subsequent selective removal of patterns from each layer. Lam holds the top market share in etch and holds the clear second share in deposition. It is more exposed to memory chipmakers for DRAM and NAND chips. It counts as top customers the largest chipmakers in the world, including TSMC, Samsung, Intel, and Micron.
<h3>Present Market Standing of Lam Research</h3>
<ul>
<li>With a trading volume of 4,135,291, the price of LRCX is down by -2.88%, reaching $75.98.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 41 days from now.</li>
</ul>
<h3>What The Experts Say On Lam Research</h3>
In the last month, 3 experts released ratings on this stock with an average target price of $82.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Bernstein persists with their Market Perform rating on Lam Research, maintaining a target price of $85. 
&#x2A; Maintaining their stance, an analyst from Wells Fargo continues to hold a Equal-Weight rating for Lam Research, targeting a price of $83. 
&#x2A; An analyst from Morgan Stanley persists with their Equal-Weight rating on Lam Research, maintaining a target price of $78. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Lam Research, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

LRCX

Spotlight on Lam Research: Analyzing the Surge in Options Activity

Kosmos Energy Ltd. ("Kosmos" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KOS#NYSE">KOS</a>) notes today's announcement by Tullow Oil plc ("Tullow") (LSE: TLW) regarding a potential transaction involving Tullow and Kosmos and confirms that it is in very preliminary discussions with Tullow regarding a possible all-share offer by Kosmos for Tullow.
There can be no certainty that any offer will be made, nor as to the terms on which any offer might be made. Pursuant to Rule 2.5 of the Code, Kosmos reserves the right to vary the form and/or mix of the offer consideration and vary the transaction structure. A further announcement will be made as and when appropriate.

Kosmos Energy Notes Announcement By Tullow Oil Regarding A Potential Transaction Involving Tullow And Kosmos And Confirms That It Is In Very Preliminary Discussions With Tullow Regarding A Possible All-Share Offer By Kosmos For Tullow

Whales with a lot of money to spend have taken a noticeably bearish stance on JPMorgan Chase.
Looking at options history for JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) we detected 29 trades.
If we consider the specifics of each trade, it is accurate to state that 34% of the investors opened trades with bullish expectations and 51% with bearish.
From the overall spotted trades, 9 are puts, for a total amount of $567,565 and 20, calls, for a total amount of $1,342,170.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $145.0 and $370.0 for JPMorgan Chase, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for JPMorgan Chase's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of JPMorgan Chase's whale trades within a strike price range from $145.0 to $370.0 in the last 30 days. 
<h3>JPMorgan Chase 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734034167_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>JPM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$13.2</td>
<td>$13.0</td>
<td>$13.2</td>
<td>$245.00</td>
<td>$264.0K</td>
<td>1.4K</td>
<td align="right">201</td>
</tr>
<tr>
<td>JPM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$39.0</td>
<td>$38.8</td>
<td>$39.0</td>
<td>$220.00</td>
<td>$195.0K</td>
<td>5.9K</td>
<td align="right">50</td>
</tr>
<tr>
<td>JPM</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$129.7</td>
<td>$125.0</td>
<td>$127.33</td>
<td>$370.00</td>
<td>$127.3K</td>
<td>0</td>
<td align="right">20</td>
</tr>
<tr>
<td>JPM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$127.5</td>
<td>$124.75</td>
<td>$126.77</td>
<td>$370.00</td>
<td>$126.7K</td>
<td>0</td>
<td align="right">0</td>
</tr>
<tr>
<td>JPM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$9.85</td>
<td>$9.5</td>
<td>$9.5</td>
<td>$290.00</td>
<td>$95.0K</td>
<td>865</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

<h3>About JPMorgan Chase</h3>
JPMorgan Chase is one of the largest and most complex financial institutions in the United States, with nearly $4.1 trillion in assets. It is organized into four major segments--consumer and community banking, corporate and investment banking, commercial banking, and asset and wealth management. JPMorgan operates, and is subject to regulation, in multiple countries.
Having examined the options trading patterns of JPMorgan Chase, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>JPMorgan Chase's Current Market Status</h3>
<ul>
<li>Trading volume stands at 3,535,176, with JPM's price down by -0.85%, positioned at $241.47.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 34 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for JPMorgan Chase with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Spotlight on JPMorgan Chase: Analyzing the Surge in Options Activity

ABEV

AZUL

BBDO

BSBR

Embraer-Empresa Brasileira De Aeronautica

ITUB

MELI

Companhia De Saneamento Basico Do Estado De Sao

VALE

Shares of Brazilian stocks are trading lower amid a rise in borrowing costs and a depreciation of the Brazilian Real.

Believes Annual Meeting Outcome is Critical to Future of the Company and that the Current Board is Best Positioned to Continue Clinical Trial Momentum, Commercialize Ampligen and Deliver Long-Term Value for Shareholders
In AIM's View, the Activist Group's Plan to Reimburse Individuals More Than $5 Million for Failed Attempts to Gain Control of the Board – Without Putting this to a Shareholder Vote – Is Grossly Irresponsible and Not in the Best Interests of All Shareholders
Reminds Shareholders that Both Leading Independent Proxy Advisory Firms – ISS and Glass Lewis – Recommended Against Giving the Dissident Nominees Control of the AIM Board, Specifically Citing Their Lack of a Plan, Among Other Issues
Highlights Activist Group Nominees Todd A. Deutsch's and Robert L. Chioini's Checkered Pasts and Affiliations with Securities Law Criminals – and that Mr. Chioini Was Fired as CEO of Rockwell Medical for His "Sustained Mismanagement" and "Blatant Disregard for Shareholder Concerns"1
Questions How Activist Group Nominee Paul Sweeney Could Function as an Independent Director Given that Mr. Kellner is Apparently the Biggest Investor in Mr. Sweeney's Private Equity Firm
AIM ImmunoTech Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIM#NYSE">AIM</a>) ("AIM" or the "Company") today issued the following statement in connection with the upcoming 2024 Annual Meeting of Stockholders (the "Annual Meeting"), presently scheduled for December 17, 2024:
With the Annual Meeting quickly approaching, it is critical that shareholders vote on the WHITE universal proxy card to re-elect all four current members of our Board of Directors (the "Board"). As shareholders consider this important decision, we ask that they keep the following in mind:

Management

Aim ImmunoTech Urges Shareholders To Vote On The White Universal Proxy Card "For" All 4 Incumbent Board Members; Believes Future Of The Co And That The Current Board Is Best Positioned To Continue Clinical Trial Momentum, Commercialize Ampligen And Deliver Long-Term Value For Shareholders

American Finl Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFG#NYSE">AFG</a>) has outperformed the market over the past 20 years by 1.51% on an annualized basis producing an average annual return of 9.92%. Currently, American Finl Gr has a market capitalization of $11.70 billion. 
Buying $1000 In AFG: If an investor had bought $1000 of AFG stock 20 years ago, it would be worth $6,717.04 today based on a price of $139.40 for AFG at the time of writing.
<h3>American Finl Gr's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734033750_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning American Finl Gr Stock In The Last 20 Years

Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q3 2024 Update

Trevi Therapeutics (TRVI) announced the positive outcome from the planned sample size re-estimation for the ongoing Phase 2b CORAL trial in idiopat...

Trevi Therapeutics provides update on Phase 2b trial of Haduvio in IPF

JonesTrading analyst Debanjana Chatterjee reiterated a Buy rating on Trevi Therapeutics (TRVI – Research Report) today and set a price target of $9...

Optimistic Buy Rating for Trevi Therapeutics Amid Promising Phase 2b Trial Results

Trevi stock rockets on Haduvio study update

Needham analyst Serge Belanger maintained a Buy rating on Trevi Therapeutics (TRVI – Research Report) today and set a price target of $8.00. Serge ...

Trevi Therapeutics: Buy Rating Affirmed Amid Positive Clinical Trial Developments and Strong Pipeline Outlook

Trevi Therapeutics (TRVI) on Thursday reported confirmation of the clearing sample size re-estimation for the Phase IIb CORAL trial in idiopathic p...

Trevi Therapeutics Phase IIb update a major de-risking event, says B. Riley

Analyst Oren Livnat from H.C. Wainwright reiterated a Buy rating on Trevi Therapeutics (TRVI – Research Report) and increased the price target to $...

Positive Outlook on Trevi Therapeutics: Stable Phase 2b Trial Results Boost Confidence in Haduvio and Market Potential

JonesResearch notes Trevi Therapeutics (TRVI) shared positive update from the planned sample size re-estimation in ongoing Phase 2b CORAL trial in ...

JonesResearch reiterates Buy rating on Trevi following positive CORAL update

H.C. Wainwright raised the firm's price target on Trevi Therapeutics (TRVI) to $7.50 from $6 and keeps a Buy rating on the shares after the company...

H.C. Wainwright ups Trevi Therapeutics target after 'best-case' for CORAL

Needham analyst Serge Belanger says Trevi Therapeutics (TRVI)' Phase 2b CORAL trial evaluating Haduvio for idiopathic pulmonary fibrosis cough unde...

Trevi Therapeutics trial analysis 'best case outcome,' says Needham

AAPL

ACHC

ADBE

ADPT

AMZN

AVGO

BBIO

BMRN

CBRE

DASH

DDOG

DLTR

EWTX

FERG

FLUT

INBX

ISRG

MSFT

NAMS

NFLX

NVDA

ORIC

PEPG

PHVS

ROIV

RPRX

TEAM

TMUS

TRVI

VKTX

WDAY

Press Releases

Trevi Therapeutics Announces Additional Analyses of Cough Relief Time from Ph2a CANAL Trial Accepted for Oral Presentation at CHEST 2024

Trevi Therapeutics Announces Appointment of James V. Cassella, Ph.D., as Chief Development Officer

Trevi Therapeutics Provides Update on Haduvio's Clinical Development Program

Trevi Therapeutics to Participate in Upcoming Commercial and Investor Conferences

Trevi Therapeutics Completes Enrollment for Phase 2a RIVER Trial in Refractory Chronic Cough

Trevi Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on November 6, 2024

Earnings

Trevi Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

Trevi Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference

Trevi Therapeutics Announces Positive Topline Results from Human Abuse Potential Study of Oral Nalbuphine

Trevi Therapeutics Announces Positive Outcome from Sample Size Re-estimation Resulting in No Change to the Current Sample Size for the Phase 2b CORAL Trial in Idiopathic Pulmonary Fibrosis Patients with Chronic Cough

Aclaris Therapeutics, Inc. - Common Stock

Aclaris Therapeutics

Amylyx Pharmaceuticals, Inc. - Common Stock

Amylyx Pharma

Alto Neuroscience

Aquestive Therapeutics, Inc. - Common Stock

Aquestive Therapeutics

Assertio Holdings

Atea Pharmaceuticals, Inc. - common stock

Atea Pharmaceuticals

BGM Group

Bioage Labs

Biote

Context Therapeutics

Contineum Therapeutics, Inc. - Common stock

Contineum Therapeutics

Journey Medical Corporation - Common Stock

Journey Medical

Eton Pharmaceuticals, Inc. - Common Stock

Eton Pharmaceuticals

Fulcrum Therapeutics, Inc. - Common Stock

Fulcrum Therapeutics

Jupiter Neurosciences, Inc. - Common Stock

Jupiter Neurosciences

Milestone Pharmaceuticals Inc. - Common Shares

Milestone Pharmaceuticals

Nektar Therapeutics

Oramed Pharmaceuticals Inc. - Common Stock

Oramed Pharmaceuticals

Procaps Gr

Revance Therapeutics, Inc. - Common Stock

Revance Therapeutics

Reviva Pharmaceuticals Holdings, Inc. - Common Stock

Reviva Pharmaceuticals

Cassava Sciences

scPharmaceuticals

Telomir Pharmaceuticals, Inc. - Common Stock

Telomir Pharmaceuticals

Ventyx Biosciences

HC Wainwright & Co.

D. Boral Capital

Needham

EF Hutton

B. Riley Securities

Trevi Therapeutics shares are trading higher after the company announced positive outcomes for the treatment of patients from its chronic cough    Phase 2b CORAL trial.

Comments

Trevi Therapeutics

Actualités

Dernières nouvelles pour Trevi Therapeutics (NASDAQ:TRVI) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL